14 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
QUPID PLUS E.R.
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Henry Schein
FDA UDI
HENRY SCHEIN, INC.·10304040051174·FILE - Channels PT Platinum - G1 21MM
Midway Select
FDA UDI
MIDWAY DENTAL SUPPLY, LLC·10843717103735·Stainless Steel K Files (Hand), Size # 15, Leng...
N/A
FDA UDI
BIOMET MICROFIXATION, INC·00841036020415·
Merit Medical®
FDA UDI
Merit Medical Systems, Inc.·00884450157282·
BACT/ALERT MB CULTURE BOTTLE
FDA 510(k)
FDA Class 1
·Microbiology
MODULAR PORP AND TORP MODEL TBD
FDA 510(k)
FDA Class 2
·Ear, Nose, Throat
OT VERIO IQ METER
FDA Adverse Event
Malfunction
·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·March 26, 2013
XENIUM 150 SYNTH HF DIALYZERSYNTHETIC FOR HEMODIALYSIS
FDA Adverse Event
Injury
·NIPRO CORPORATION USD·Product code KDI·March 16, 2011
GORE EXCLUDER AAA ENDOPROSTHESIS
FDA Adverse Event
Death
·W. L. GORE & ASSOCIATES, INC.·Product code MIH·March 28, 2008
INNOVA
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC CORPORATION·Product code NIP·October 22, 2020
VS3 Iridium Visionsense Infrared (IR) Fluorescence Miniature Microscope (MMS-IR) Product Number: 174-0012
FDA Enforcement
Class II
·Ongoing·Visionsense, Ltd.·November 30, 2022
Aurora 4 Series, Aurora 7 lighthead; Models: AUA7 (including TV models). The Aurora Series is intended to illuminate the surgical field and ensure visibility of the surgical site.
FDA Enforcement
Class II
·Ongoing·DKK Dai-Ichi Shomei Co., Ltd.·August 21, 2024
The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.
FDA Enforcement
Class II
·Terminated·Welch Allyn Protocol, Inc·January 15, 2014